Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junming Yue

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|June 17, 2022
Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143Peixin Dong, Feng Wang, Mohammad Taheri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2019
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genesPeixin Dong, Ying Xiong, Junming Yue, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 31, 2019
DGCR8 expression is altered in children with congenital heart defectsZhikuan Guo, Baoping Li, Peng Tian, et al.
Cancers|August 10, 2019
MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment FormationDaozhi Xu, Peixin Dong, Ying Xiong, et al.
Cells|March 11, 2020
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1Daozhi Xu, Peixin Dong, Ying Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasisShelby Waddell, Guannan Zhao, Ziping Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
VERU-111, an Orally Available Tubulin Inhibitor, Suppresses Ovarian Tumor Growth and MetastasisShelby Waddell, Guannan Zhao, Ziping Liu, et al.
European Journal of Medicinal Chemistry|August 9, 2021
Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffoldNajah Albadari, Shanshan Deng, Hao Chen, et al.
The Journal of Biological Chemistry|August 8, 2013
Comprehensive analysis of microRNA (miRNA) targets in breast cancer cellsMeiyun Fan, Raisa Krutilina, Jing Sun, et al.
Oncotarget|December 8, 2017
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cellsGuannan Zhao, Qinghui Wang, Qingqing Gu, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|June 17, 2022
Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143Peixin Dong, Feng Wang, Mohammad Taheri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2019
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genesPeixin Dong, Ying Xiong, Junming Yue, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 31, 2019
DGCR8 expression is altered in children with congenital heart defectsZhikuan Guo, Baoping Li, Peng Tian, et al.
Cancers|August 10, 2019
MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment FormationDaozhi Xu, Peixin Dong, Ying Xiong, et al.
Cells|March 11, 2020
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1Daozhi Xu, Peixin Dong, Ying Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasisShelby Waddell, Guannan Zhao, Ziping Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
VERU-111, an Orally Available Tubulin Inhibitor, Suppresses Ovarian Tumor Growth and MetastasisShelby Waddell, Guannan Zhao, Ziping Liu, et al.
European Journal of Medicinal Chemistry|August 9, 2021
Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffoldNajah Albadari, Shanshan Deng, Hao Chen, et al.
The Journal of Biological Chemistry|August 8, 2013
Comprehensive analysis of microRNA (miRNA) targets in breast cancer cellsMeiyun Fan, Raisa Krutilina, Jing Sun, et al.
Oncotarget|December 8, 2017
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cellsGuannan Zhao, Qinghui Wang, Qingqing Gu, et al.
Pageof 11